Harlan Laboratories Continues Strategic Growth with Expansion of South European Services Facility

INDIANAPOLIS, Sept. 12, 2013 /PRNewswire/ -- Harlan Laboratories, a leading contract research organization and research models and services company, announced today that the company has expanded its specialty research production facility in Southern Europe. The expansion allows Harlan Laboratories to provide its complete portfolio of contract breeding and health monitoring services to customers in both mainland Europe and the U.K.

"Expanding our facility in Southern Europe is a significant part of our global growth strategy to provide pharmaceutical and biotech companies throughout Europe with the highest quality services that support their research models," said Joe Meyer, Vice President of Global Commercial Operations, Harlan Laboratories. "The expansion of our contract breeding and health monitoring services facility reinforces Harlan Laboratories' commitment to provide researchers around the globe with critical services that ensure the specialized models they use in their research will produce reliable and consistent results."  

The expanded Southern European operations were designed to mirror Harlan's contract breeding service capabilities already established in the U.K. These services include rederivation, cryopreservation, revitalization, colony management, contract breeding and quarantine services.

As with all of Harlan Laboratories' production facilities, the new site was designed with the utmost consideration for the health and welfare of research models. The enhanced facility includes dedicated areas for quarantine to reduce the transmission of pathogens between animal colonies and also features an expanded and updated health monitoring laboratory. In addition, Harlan Laboratories incorporated the LabTracks software system, by Locus Technology, Inc., which provides a fully integrated animal husbandry network that supports real-time inventory data, records on cryopreserved materials, as well as information on cage capacity and the health status of animals within the facility. 

The Southern European facility expansion comes on the heels of Harlan Laboratories' recent announcement that the company has increased its specialty model production capacity in North America by more than 30 percent with expansions of its facilities in Indianapolis, Indiana and Livermore, California.

For more information on Harlan Laboratories, please visit www.Harlan.com.

About Harlan Laboratories, Inc.
Harlan Laboratories, Inc. is a leading provider of essential, pre-clinical and non-clinical contract research, research models, animal diets, and services to the pharmaceutical, biotech, medical device, agrochemical and chemical industries, as well as universities, government, and other research organizations. Our focus is on providing customers with products and services to optimize the discovery and safety of new medicines and compounds. Harlan Laboratories is a privately held company.                                           

PRESS CONTACT: 
Michael Clark 
Miller Brooks, Inc. 
317.873.8100
[email protected]

SOURCE Harlan Laboratories, Inc.